Primary Job Title Managing Director & Co-Founder Primary Organization 
Enterprise Partners
Location San Diego, California, United States Regions Greater San Diego Area, West Coast, Western US Gender Male Also Known As Andrew E. Senyei
Investor Type
LinkedIn View on LinkedIn
Drew is a managing director & Co-Founder at Enterprise Partners where he leads the life science practice. Drew focuses on investments in pharmaceuticals, biopharmaceuticals, diagnostics, medical devices and consumer healthcare. Drew has served on over 25 public and private boards including Adeza Biomedical, NuVasive, Corixa Corp., Ligand
Pharmaceuticals, Nanogen, Inc., and Discovery Partners.
Drew currently sits on the boards of current Enterprise portfolio companies including: Scoperta, Inc., Ascenta Therapeutics, Celladon, Celula, Complete Genomics, Ophthonix, TargeGen and Scoperta, Inc.
Prior to joining Enterprise Partners in 1987, Drew was a physician and entrepreneur. While still a medical student at Northwestern University, Drew developed a drug delivery device and licensed it to Eli Lilly. Subsequently Drew joined Lilly as consultant while completing his internship at the University of California Irvine.
Drew holds a B.S. from Occidental College and an M.D. from Northwestern University. Drew completed his residency in obstetrics and gynecology at the University of California, Irvine, and holds 20 patents in healthcare related products and services including the first and only biochemical test that predicts preterm delivery. The test is available worldwide and has been used by over a million women.
Drew focuses his philanthropic efforts in education and the arts. He founded Equity in Education at The Bishops School to encourage entrepreneurs to donate stock for educational programs.
Drew is a member of Northwestern University’s board of trustees, he is chairman of the board of UCSD’s Jacobs School of Engineering and is a member of the board of advisors for UCSD’s School of Medicine.
Drew is on San Diego’s BIOCOM board of directors and also serves as president of the San Diego Opera. In January, 2006, Drew was named one of the Top 100 VC’s in Forbes Magazine’s 2006 Annual Midas List.
